CN1112834A - Oral liquid for curing hepatitis B, and method for prodn. of same - Google Patents
Oral liquid for curing hepatitis B, and method for prodn. of same Download PDFInfo
- Publication number
- CN1112834A CN1112834A CN 94109284 CN94109284A CN1112834A CN 1112834 A CN1112834 A CN 1112834A CN 94109284 CN94109284 CN 94109284 CN 94109284 A CN94109284 A CN 94109284A CN 1112834 A CN1112834 A CN 1112834A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- juice
- hepatitis
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The oral liquid is preod. from root of bupleurum, rhizome of nutgrass flatsedge, curcuma root, root of Chinese angelica and other 24 ingredients of Chinese herbal medicines, it is indicated for treatment of hepatitis B, and features short course of treatment, quick efficacy, safety and no side-effect.
Description
The present invention relates to a kind of manufacture method of controlling the hepatitis B medicine and products thereof.
There are the various hepatitis B medicines of controlling to sell at present on the market, certain therapeutic effect is arranged, but all there is not late result, can not effect a radical cure hepatitis B, so that the hepatitis B disease is still wildness and stretches uncontrollable, many hepatitis B patients lose normal viability because of obstinate, even are developed to the serious disastrous effect of " sclerosis " " canceration ".Though the hepatitis B patient who has can obtain " false ", the misfortune that be unable to escape recurrence eventually, cancerates, this just gives the human human body and brings great infringement mentally.
The object of the present invention is to provide and a kind ofly can fundamentally cure hepatitis B, treatment cycle is short, and instant effect is safe and reliable, Bao oral liquid of the hepatitis B that has no side effect and preparation method thereof.
The technical solution of the present invention i.e. manufacture method of the Bao oral liquid of this hepatitis B is as follows:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
It is that obtaining concentration is 45~55%(weight/volume in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration) the reinforcement solution that looses;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with 92~95%(volume) main body decoct juice, 1~2%(volume) broken flavor fourth liquid, 2~4%(volume) reinforcement loose solution and 2~4%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
The Bao oral liquid of hepatitis B of the present invention can be made concentrated oral liquid as required, or is mixed with the dilution oral liquid with distilled water, and the oral liquid of 500 milliliters of not diluted can divide and take in 3~7 days.Patient can take 30~90 days continuously according to the weight of the state of an illness; General patient can cure a course of treatment, and more serious 2~3 courses of treatment of need treatment, 3 months is a course of treatment.
The Bao oral liquid of hepatitis B of the present invention can fundamentally be cured hepatitis B, and clinical effective rate is 100%, and cure rate and state of an illness negative conversion rate are more than 90%, no longer recurrence after healing, lifetime immunity and cross immunity.The treatment cycle of this oral liquid is short, and instant effect is safe and reliable, has no side effect.
Below in conjunction with embodiment and clinical example the present invention is described in more detail.
Embodiment 1:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 3% CAIHU, 4.5% Rhizoma Cyperi, 3.8% radix curcumae, 5.2% Radix Angelicae Sinensis, 5% Radix Paeoniae Alba, 4% Rhizoma Atractylodis Macrocephalae, 6% Poria, the 4.5%th full building, 5.4% Bulbus Allii Macrostemonis, 6% Fructus Lycii, 4% Radix Glycyrrhizae, 3% Herba Menthae, 5% Fructus Gardeniae, 5.5% Herba Artemisiae Scopariae, 5.5% Cymbidium ensifolium (L.) Sw. root, 4% Radix Scutellariae, 7% Radix Sophorae Flavescentis, 5% Radix Rehmanniae, 3% Fructus Aurantii, 6% Fructus Crataegi, 4% Semen Raphani (the above-mentioned unit of weight that is) mix homogeneously, make main body with conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, the Radix Notoginseng with 55%, 2% Dan Xiang, 2% SHANGMEIQI, 0.8% Oleum menthae, 10.2% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration and are in 95% the ethanol, and obtaining concentration is the 50%(weight/volume) reinforcement solution;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with the 95%(volume) main body decoct juice, 1%(volume) broken flavor fourth liquid, 2%(volume) reinforcement loose solution and 2%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
Embodiment 2:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 20 gram CAIHU, 25 gram Rhizoma Cyperis, 23 gram radix curcumaes, 22 gram Radix Angelicae Sinensis, the 20 gram Radix Paeoniae Albas, the 30 gram Rhizoma Atractylodis Macrocephalaes, 25 gram Poria, 25 gram Jin Lou, 22.5 gram Bulbus Allii Macrostemonis, 32.5% Fructus Lyciis, 25 gram Radix Glycyrrhizaes, 10 gram Herba Menthaes, 30 Keshan Cape jasmines, 22.5 gram Herba Artemisiae Scopariaes, 22.5 gram Radix Isatidiss, 30 gram Radix Scutellariaes, 25 gram Radix Sophorae Flavescentiss, the 30 gram Radix Rehmanniae, 20 gram Fructus Aurantiis, 25 Keshan short, bristly hair or beards, 15 gram Semen Raphani mix homogeneously, decoct with conventional method and to obtain main body and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, with 58 gram Radix Notoginsengs, 28 Ke Dan townshiies, 3 gram SHANGMEIQIs, 1 gram Oleum menthae, 10 gram Rhizoma Acori Graminei mix homogeneously, be immersed in concentration and be in 95% the ethanol, obtain 200 milliliters the reinforcement solution that looses;
D, 100 gram Herba Pogostemoniss are decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, 92 milliliters of main bodys are decocted juice, 2 milliliters of broken flavor fourth liquid, 4 milliliters strengthen loosing solution and 4 milliliters of Herba Pogostemoniss decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain the Bao oral liquid of 100 milliliters of hepatitis B.
Clinical example 1:
Patient: the technique center Wang Li of Shiyan City, Hubei Province No. 2 Automobile Factory, do liver function test and find that GPT increases, surface antigen belongs to positive, be diagnosed as hepatitis B, do not see obvious improvement, after take the Bao oral liquid of trimestral hepatitis B of the present invention through hospitalize, the every index of liver function test is normal, appetite increases, and has rosy cheeks, and all malaise symptoms are thoroughly eliminated.
Clinical example 2:
Patient: the Wu Qiuping of production scheduling place of Shiyan City, Hubei Province No. 2 Automobile Factory, suffer from the serious symptom hepatitis B did not heal in hospital in four months, no appetite, malaise is after take the Bao oral liquid of trimestral hepatitis B of the present invention, liver function check and ultrasound diagnosis index are normal, special examination two double full feminine genders that belong to, physical recovery has been married as before, given birth to child, always operate as normal and life.
Claims (1)
1, manufacture method of a kind of hepatitis B oral liquid and products thereof is characterized in that:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid,
It is in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration, obtaining concentration is the diffusing solution of reinforcement of 45~55% (weight/volume)
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice,
The loose Herba Pogostemonis of solution and 2~4% (volume) of e, the reinforcement that the main body of 92~95% (volumes) is decocted broken flavor fourth liquid, 2~4% (volumes) of juice, 1~2% (volume) decocts the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94109284 CN1112834A (en) | 1994-08-29 | 1994-08-29 | Oral liquid for curing hepatitis B, and method for prodn. of same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94109284 CN1112834A (en) | 1994-08-29 | 1994-08-29 | Oral liquid for curing hepatitis B, and method for prodn. of same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1112834A true CN1112834A (en) | 1995-12-06 |
Family
ID=5033848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94109284 Pending CN1112834A (en) | 1994-08-29 | 1994-08-29 | Oral liquid for curing hepatitis B, and method for prodn. of same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1112834A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1054540C (en) * | 1998-01-12 | 2000-07-19 | 李铁敏 | Anti-hepatitis B virus preparation of traditional Chinese medicine and its preparing method |
CN1061554C (en) * | 1998-11-19 | 2001-02-07 | 潘建新 | Chinese patent drug for curing hepatitis B |
CN1061869C (en) * | 1996-09-10 | 2001-02-14 | 吴荫福 | Recovering powder for hepatitis B |
CN1098089C (en) * | 1998-04-28 | 2003-01-08 | 天津市新迪亚医药新技术发展有限公司 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
CN100382824C (en) * | 2006-04-24 | 2008-04-23 | 辽宁本溪三药有限公司 | Chinese traditional medicine for treating chronic hepatitis, and preparation method |
US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
-
1994
- 1994-08-29 CN CN 94109284 patent/CN1112834A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1061869C (en) * | 1996-09-10 | 2001-02-14 | 吴荫福 | Recovering powder for hepatitis B |
CN1054540C (en) * | 1998-01-12 | 2000-07-19 | 李铁敏 | Anti-hepatitis B virus preparation of traditional Chinese medicine and its preparing method |
CN1098089C (en) * | 1998-04-28 | 2003-01-08 | 天津市新迪亚医药新技术发展有限公司 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
CN1061554C (en) * | 1998-11-19 | 2001-02-07 | 潘建新 | Chinese patent drug for curing hepatitis B |
US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
CN100382824C (en) * | 2006-04-24 | 2008-04-23 | 辽宁本溪三药有限公司 | Chinese traditional medicine for treating chronic hepatitis, and preparation method |
CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1186043C (en) | Exterior-applied medicine for treating osteopathy | |
CN1305844A (en) | Medicine for treating congestive heart failure | |
CN101190323A (en) | Orally-taken traditional Chinese medicine soup acquired immuno-deficiency syndrome | |
CN1193775C (en) | Rheumatoid disease treating capsule | |
CN1112834A (en) | Oral liquid for curing hepatitis B, and method for prodn. of same | |
CN1994453B (en) | Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis | |
CN1111522A (en) | Compound islets Langerhans regenerated capsule | |
CN1657067A (en) | Chinese medicine for treating psoriasis | |
CN1120943A (en) | Nose opening capsule and its preparation method | |
CN1036699A (en) | " skin medicine " liquid medicine compound method | |
CN1365819A (en) | Medicine for treating apoplexy | |
CN1331996A (en) | Hepatitis B treaitng pill | |
CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
CN1087821A (en) | A kind of medicament and preparation method of removing acne | |
CN1084630C (en) | Mastopathy treating ointment | |
CN1255149C (en) | Combination of medication | |
CN1054767C (en) | Pharmaceutical preparation for treatment of leukoderma | |
CN1322558A (en) | Liver cancer resisting medicine | |
CN1565544A (en) | Medicine for treating cold disease | |
CN1035954A (en) | Fluid for seasonal illness | |
CN1117856A (en) | Medicine for radically curing constipation | |
CN1077797C (en) | Chinese medicine powder preparation for curing leukemia | |
CN1129578A (en) | Formulation of Ganmaosuyusan for curing common cold | |
CN1061554C (en) | Chinese patent drug for curing hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |